Skip to main content
NCBI home page
Molecular Biology of the Cell logoLink to Molecular Biology of the Cell
. 1996 May;7(5):719–729. doi: 10.1091/mbc.7.5.719

Expression and activity of serum response factor is required for expression of the muscle-determining factor MyoD in both dividing and differentiating mouse C2C12 myoblasts.

C Gauthier-Rouviere 1, M Vandromme 1, D Tuil 1, N Lautredou 1, M Morris 1, M Soulez 1, A Kahn 1, A Fernandez 1, N Lamb 1
PMCID: PMC275925  PMID: 8744946

Abstract

To understand the mechanism by which the serum response factor (SRF) is involved in the process of skeletal muscle differentiation, we have assessed the effect of inhibiting SRF activity or synthesis on the expression of the muscle-determining factor MyoD. Inhibition of SRF activity in mouse myogenic C2C12 cells through microinjection of either the SRE oligonucleotide (which acts by displacing SRF proteins from the endogenous SRE sequences), purified SRF-DB (a 30-kDa portion of SRF containing the DNA-binding domain of SRF, which acts as a dominant negative mutant in vivo), or purified anti-SRF antibodies rapidly prevents the expression of MyoD. Moreover, the rapid shutdown of MyoD expression after in vivo inhibition of SRF activity is observed not only in proliferating myoblasts but also in myoblasts cultured under differentiating conditions. Additionally, by using a cellular system expressing a glucocorticoid-inducible antisense-SRF (from aa 74 to 244) we have shown that blocking SRF expression by dexamethasone induction of antisense SRF results in the lack of MyoD expression as probed by both immunofluorescence and Northern blot analysis. Taken together these data demonstrate that SRF expression and activity are required for the expression of the muscle-determining factor MyoD.

Full text

PDF
719

Images in this article

721Image
on p.721
723Image
on p.723
725Image
on p.725
725Image
on p.725

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blau H. M., Chiu C. P., Webster C. Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell. 1983 Apr;32(4):1171–1180. doi: 10.1016/0092-8674(83)90300-8. [DOI] [PubMed] [Google Scholar]
  2. Boxer L. M., Miwa T., Gustafson T. A., Kedes L. Identification and characterization of a factor that binds to two human sarcomeric actin promoters. J Biol Chem. 1989 Jan 15;264(2):1284–1292. [PubMed] [Google Scholar]
  3. Breitbart R. E., Liang C. S., Smoot L. B., Laheru D. A., Mahdavi V., Nadal-Ginard B. A fourth human MEF2 transcription factor, hMEF2D, is an early marker of the myogenic lineage. Development. 1993 Aug;118(4):1095–1106. doi: 10.1242/dev.118.4.1095. [DOI] [PubMed] [Google Scholar]
  4. Catala F., Wanner R., Barton P., Cohen A., Wright W., Buckingham M. A skeletal muscle-specific enhancer regulated by factors binding to E and CArG boxes is present in the promoter of the mouse myosin light-chain 1A gene. Mol Cell Biol. 1995 Aug;15(8):4585–4596. doi: 10.1128/mcb.15.8.4585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Choi J., Costa M. L., Mermelstein C. S., Chagas C., Holtzer S., Holtzer H. MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes. Proc Natl Acad Sci U S A. 1990 Oct;87(20):7988–7992. doi: 10.1073/pnas.87.20.7988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Concordet J. P., Salminen M., Demignon J., Moch C., Maire P., Kahn A., Daegelen D. An opportunistic promoter sharing regulatory sequences with either a muscle-specific or a ubiquitous promoter in the human aldolase A gene. Mol Cell Biol. 1993 Jan;13(1):9–17. doi: 10.1128/mcb.13.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cserjesi P., Olson E. N. Myogenin induces the myocyte-specific enhancer binding factor MEF-2 independently of other muscle-specific gene products. Mol Cell Biol. 1991 Oct;11(10):4854–4862. doi: 10.1128/mcb.11.10.4854. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ernst H., Walsh K., Harrison C. A., Rosenthal N. The myosin light chain enhancer and the skeletal actin promoter share a binding site for factors involved in muscle-specific gene expression. Mol Cell Biol. 1991 Jul;11(7):3735–3744. doi: 10.1128/mcb.11.7.3735. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gauthier-Rouvière C., Basset M., Blanchard J. M., Cavadore J. C., Fernandez A., Lamb N. J. Casein kinase II induces c-fos expression via the serum response element pathway and p67SRF phosphorylation in living fibroblasts. EMBO J. 1991 Oct;10(10):2921–2930. doi: 10.1002/j.1460-2075.1991.tb07842.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gauthier-Rouvière C., Cavadore J. C., Blanchard J. M., Lamb N. J., Fernandez A. p67SRF is a constitutive nuclear protein implicated in the modulation of genes required throughout the G1 period. Cell Regul. 1991 Jul;2(7):575–588. doi: 10.1091/mbc.2.7.575. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gauthier-Rouvière C., Caï Q. Q., Lautredou N., Fernandez A., Blanchard J. M., Lamb N. J. Expression and purification of the DNA-binding domain of SRF: SRF-DB, a part of a DNA-binding protein which can act as a dominant negative mutant in vivo. Exp Cell Res. 1993 Dec;209(2):208–215. doi: 10.1006/excr.1993.1303. [DOI] [PubMed] [Google Scholar]
  12. Gilman M. Z., Wilson R. N., Weinberg R. A. Multiple protein-binding sites in the 5'-flanking region regulate c-fos expression. Mol Cell Biol. 1986 Dec;6(12):4305–4316. doi: 10.1128/mcb.6.12.4305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Joliot V., Demma M., Prywes R. Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by serum response factor. Nature. 1995 Feb 16;373(6515):632–635. doi: 10.1038/373632a0. [DOI] [PubMed] [Google Scholar]
  14. Klamut H. J., Gangopadhyay S. B., Worton R. G., Ray P. N. Molecular and functional analysis of the muscle-specific promoter region of the Duchenne muscular dystrophy gene. Mol Cell Biol. 1990 Jan;10(1):193–205. doi: 10.1128/mcb.10.1.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lassar A. B., Davis R. L., Wright W. E., Kadesch T., Murre C., Voronova A., Baltimore D., Weintraub H. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell. 1991 Jul 26;66(2):305–315. doi: 10.1016/0092-8674(91)90620-e. [DOI] [PubMed] [Google Scholar]
  16. Lassar A. B., Paterson B. M., Weintraub H. Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell. 1986 Dec 5;47(5):649–656. doi: 10.1016/0092-8674(86)90507-6. [DOI] [PubMed] [Google Scholar]
  17. Leibham D., Wong M. W., Cheng T. C., Schroeder S., Weil P. A., Olson E. N., Perry M. Binding of TFIID and MEF2 to the TATA element activates transcription of the Xenopus MyoDa promoter. Mol Cell Biol. 1994 Jan;14(1):686–699. doi: 10.1128/mcb.14.1.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. McDermott J. C., Cardoso M. C., Yu Y. T., Andres V., Leifer D., Krainc D., Lipton S. A., Nadal-Ginard B. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol Cell Biol. 1993 Apr;13(4):2564–2577. doi: 10.1128/mcb.13.4.2564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Minty A., Kedes L. Upstream regions of the human cardiac actin gene that modulate its transcription in muscle cells: presence of an evolutionarily conserved repeated motif. Mol Cell Biol. 1986 Jun;6(6):2125–2136. doi: 10.1128/mcb.6.6.2125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Miwa T., Kedes L. Duplicated CArG box domains have positive and mutually dependent regulatory roles in expression of the human alpha-cardiac actin gene. Mol Cell Biol. 1987 Aug;7(8):2803–2813. doi: 10.1128/mcb.7.8.2803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Mohun T. J., Chambers A. E., Towers N., Taylor M. V. Expression of genes encoding the transcription factor SRF during early development of Xenopus laevis: identification of a CArG box-binding activity as SRF. EMBO J. 1991 Apr;10(4):933–940. doi: 10.1002/j.1460-2075.1991.tb08027.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Mohun T., Garrett N., Treisman R. Xenopus cytoskeletal actin and human c-fos gene promoters share a conserved protein-binding site. EMBO J. 1987 Mar;6(3):667–673. doi: 10.1002/j.1460-2075.1987.tb04806.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Murre C., McCaw P. S., Vaessin H., Caudy M., Jan L. Y., Jan Y. N., Cabrera C. V., Buskin J. N., Hauschka S. D., Lassar A. B. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell. 1989 Aug 11;58(3):537–544. doi: 10.1016/0092-8674(89)90434-0. [DOI] [PubMed] [Google Scholar]
  24. Nadal-Ginard B. Commitment, fusion and biochemical differentiation of a myogenic cell line in the absence of DNA synthesis. Cell. 1978 Nov;15(3):855–864. doi: 10.1016/0092-8674(78)90270-2. [DOI] [PubMed] [Google Scholar]
  25. Norman C., Runswick M., Pollock R., Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor that binds to the c-fos serum response element. Cell. 1988 Dec 23;55(6):989–1003. doi: 10.1016/0092-8674(88)90244-9. [DOI] [PubMed] [Google Scholar]
  26. Nurrish S. J., Treisman R. DNA binding specificity determinants in MADS-box transcription factors. Mol Cell Biol. 1995 Aug;15(8):4076–4085. doi: 10.1128/mcb.15.8.4076. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Papadopoulos N., Crow M. T. Transcriptional control of the chicken cardiac myosin light-chain gene is mediated by two AT-rich cis-acting DNA elements and binding of serum response factor. Mol Cell Biol. 1993 Nov;13(11):6907–6918. doi: 10.1128/mcb.13.11.6907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Perez-Albuerne E. D., Schatteman G., Sanders L. K., Nathans D. Transcriptional regulatory elements downstream of the JunB gene. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11960–11964. doi: 10.1073/pnas.90.24.11960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Prywes R., Roeder R. G. Purification of the c-fos enhancer-binding protein. Mol Cell Biol. 1987 Oct;7(10):3482–3489. doi: 10.1128/mcb.7.10.3482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Santoro I. M., Walsh K. Natural and synthetic DNA elements with the CArG motif differ in expression and protein-binding properties. Mol Cell Biol. 1991 Dec;11(12):6296–6305. doi: 10.1128/mcb.11.12.6296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sartorelli V., Webster K. A., Kedes L. Muscle-specific expression of the cardiac alpha-actin gene requires MyoD1, CArG-box binding factor, and Sp1. Genes Dev. 1990 Oct;4(10):1811–1822. doi: 10.1101/gad.4.10.1811. [DOI] [PubMed] [Google Scholar]
  32. Tapscott S. J., Davis R. L., Thayer M. J., Cheng P. F., Weintraub H., Lassar A. B. MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science. 1988 Oct 21;242(4877):405–411. doi: 10.1126/science.3175662. [DOI] [PubMed] [Google Scholar]
  33. Tapscott S. J., Lassar A. B., Weintraub H. A novel myoblast enhancer element mediates MyoD transcription. Mol Cell Biol. 1992 Nov;12(11):4994–5003. doi: 10.1128/mcb.12.11.4994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Taylor A., Erba H. P., Muscat G. E., Kedes L. Nucleotide sequence and expression of the human skeletal alpha-actin gene: evolution of functional regulatory domains. Genomics. 1988 Nov;3(4):323–336. doi: 10.1016/0888-7543(88)90123-1. [DOI] [PubMed] [Google Scholar]
  35. Taylor M., Treisman R., Garrett N., Mohun T. Muscle-specific (CArG) and serum-responsive (SRE) promoter elements are functionally interchangeable in Xenopus embryos and mouse fibroblasts. Development. 1989 May;106(1):67–78. doi: 10.1242/dev.106.1.67. [DOI] [PubMed] [Google Scholar]
  36. Treisman R., Ammerer G. The SRF and MCM1 transcription factors. Curr Opin Genet Dev. 1992 Apr;2(2):221–226. doi: 10.1016/s0959-437x(05)80277-1. [DOI] [PubMed] [Google Scholar]
  37. Treisman R. Identification and purification of a polypeptide that binds to the c-fos serum response element. EMBO J. 1987 Sep;6(9):2711–2717. doi: 10.1002/j.1460-2075.1987.tb02564.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Treisman R. The SRE: a growth factor responsive transcriptional regulator. Semin Cancer Biol. 1990 Feb;1(1):47–58. [PubMed] [Google Scholar]
  39. Treisman R. Transient accumulation of c-fos RNA following serum stimulation requires a conserved 5' element and c-fos 3' sequences. Cell. 1985 Oct;42(3):889–902. doi: 10.1016/0092-8674(85)90285-5. [DOI] [PubMed] [Google Scholar]
  40. Tuil D., Clergue N., Montarras D., Pinset C., Kahn A., Phan-Dinh-Tuy F. CC Ar GG boxes, cis-acting elements with a dual specificity. Muscle-specific transcriptional activation and serum responsiveness. J Mol Biol. 1990 Jun 20;213(4):677–686. doi: 10.1016/S0022-2836(05)80255-4. [DOI] [PubMed] [Google Scholar]
  41. Tuil D., Soulez M., Montarras D., Pinset C., Kahn A., Phan-Dinh-Tuy F. Activation of gene expression via CArG boxes during myogenic differentiation. Exp Cell Res. 1993 Mar;205(1):32–38. doi: 10.1006/excr.1993.1054. [DOI] [PubMed] [Google Scholar]
  42. Vandromme M., Carnac G., Gauthier-Rouvière C., Fesquet D., Lamb N., Fernandez A. Nuclear import of the myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD. J Cell Sci. 1994 Feb;107(Pt 2):613–620. doi: 10.1242/jcs.107.2.613. [DOI] [PubMed] [Google Scholar]
  43. Vandromme M., Gauthier-Rouvière C., Carnac G., Lamb N., Fernandez A. Serum response factor p67SRF is expressed and required during myogenic differentiation of both mouse C2 and rat L6 muscle cell lines. J Cell Biol. 1992 Sep;118(6):1489–1500. doi: 10.1083/jcb.118.6.1489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Walsh K., Schimmel P. DNA-binding site for two skeletal actin promoter factors is important for expression in muscle cells. Mol Cell Biol. 1988 Apr;8(4):1800–1802. doi: 10.1128/mcb.8.4.1800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Weintraub H., Davis R., Tapscott S., Thayer M., Krause M., Benezra R., Blackwell T. K., Turner D., Rupp R., Hollenberg S. The myoD gene family: nodal point during specification of the muscle cell lineage. Science. 1991 Feb 15;251(4995):761–766. doi: 10.1126/science.1846704. [DOI] [PubMed] [Google Scholar]
  46. Wong M. W., Pisegna M., Lu M. F., Leibham D., Perry M. Activation of Xenopus MyoD transcription by members of the MEF2 protein family. Dev Biol. 1994 Dec;166(2):683–695. doi: 10.1006/dbio.1994.1347. [DOI] [PubMed] [Google Scholar]
  47. Yu Y. T., Breitbart R. E., Smoot L. B., Lee Y., Mahdavi V., Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 1992 Sep;6(9):1783–1798. doi: 10.1101/gad.6.9.1783. [DOI] [PubMed] [Google Scholar]
  48. Zhu H., Joliot V., Prywes R. Role of transcription factor TFIIF in serum response factor-activated transcription. J Biol Chem. 1994 Feb 4;269(5):3489–3497. [PubMed] [Google Scholar]
  49. Zhu H., Roy A. L., Roeder R. G., Prywes R. Serum response factor affects preinitiation complex formation by TFIID in vitro. New Biol. 1991 May;3(5):455–464. [PubMed] [Google Scholar]

Articles from Molecular Biology of the Cell are provided here courtesy of American Society for Cell Biology

RESOURCES